Clinical decision support via alert tool
OtherThe alert tool displays the risk of hypoglycemia for outpatients with diabetes mellitus.
NCT Number: NCT04177147
Hypoglycemia (HG) is common and can be dangerous in diabetes mellitus, so identifying patients at risk may lead to useful preventive strategies and improved quality of care and health outcomes. This study will test the implementation of a computerized alert tool for clinicians.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Diabetes mellitus is one of the most common non-communicable diseases worldwide and is a major cause of morbidity and mortality. An estimated 346 million people had diabetes in 2011, and diabetes is predicted to become the seventh leading cause of death in the world by the year 2030. In the United States, the incidence of diabetes nearly tripled between 1990 and 2010, with 1.9 million new cases diagnosed in 2010. Hypoglycemia (HG) is recognized as a limiting factor in optimal glycemic management of patients with diabetes. This potentially costly condition, occurring in approximately 20% to 60% of patients who receive oral medications for diabetes, threatens patient safety, quality of life, and potentially, cardiovascular health. Investigators have identified risk factors for HG, built a risk calculator for use by clinicians, integrated the calculator into the G3 electronic medical record system, and demonstrated our ability to collect data about outcomes. In this project, investigators studied the outcomes of implementing the risk calculator tool into clinical practice in ambulatory primary care. The findings and tools developed from this project will promote improved patient safety and medical care for diabetes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
The study included clinicians who were scheduled to provide primary care during the four-month intervention period.
Inclusion criteria
for patients:
Exclusion criteria
for patients:
N/A
The alert tool displays the risk of hypoglycemia for outpatients with diabetes mellitus.
Time frame: Five-month follow-up period
Participants with hypoglycemia had blood glucose level less than 70 mg/dL
Time frame: Five-month follow-up period
Prescriptions for insulin and sulfonylurea drugs are assessed
Time frame: Five-month follow-up period
Includes emergency encounters
Time frame: Five-month follow-up period
Text analysis of medical encounter notes
Time frame: Five-month follow-up period
Mean and SD
Indiana University
Other
Acronym: HG_Tool
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06353217
Diabetes Mellitus, Endocrine System Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT03406897
Autoimmune Diseases, Diabetes Mellitus
Miami, Florida, United States
View Trial DetailsNCT05442853
Critical Illness, Diabetes Mellitus
Gainesville, Florida, United States
View Trial DetailsNCT05597605
Acid-Base Imbalance, Acidosis
Antwerp, Belgium
View Trial Details